A congressional effort to reach a deal to lower prescription drug prices this year seemed on a path to derailment Wednesday amid political escalation on several fronts.

House Republicans took a hard line against a major plan from House Speaker Nancy Pelosi (D-Calif.), in the first committee hearing on her proposal to authorize government negotiation of certain high-priced drugs.

Later in the afternoon, Senate Finance Committee Chair Chuck Grassley (R-Iowa) acknowledged his effort with ranking member Sen. Ron Wyden (D-Ore.) to get their embattled proposal on the Senate floor may not happen this year and could slip into early 2020 when when the presidential election will overshadow congressional activity….

Read the full Modern Healthcare article